RNA, 7SL, cytoplasmic 502, pseudogene (RN7SL502P)

RN7SL502P (RNA, 7SL, cytoplasmic 502, pseudogene) is a human pseudogene corresponding to the 7SL RNA gene family. 7SL RNA itself is a noncoding RNA component of the cytoplasmic signal recognition particle (SRP), which is involved in the targeting of secretory proteins to the endoplasmic reticulum but does not itself act as a receptor, enzyme, or other conventional therapeutic target[3][4]. RN7SL pseudogenes like RN7SL502P are nonfunctional genomic sequences derived from the 7SL RNA gene, usually as a result of reverse transcription and random integration into the genome, and do not produce functional RNA or protein. They are not considered drug targets or implicated directly in disease mechanisms, and information on their potential biological functions, roles in disease, or druggability is lacking[5].\n\nAdditional context:\n- 7SL RNA pseudogenes are common in the human genome and primarily consist of truncated or mutated copies of the original 7SL RNA gene[5].\n- The functional 7SL RNA participates in the SRP pathway for co-translational translocation of proteins, but the pseudogenes are inactive and not known to serve any canonical biological or pharmacological role[3][4].\n- There is no evidence from authoritative databases or reviews indicating therapeutic, biomarker, or pathogenic roles for RN7SL502P specifically.\n- This entry is somewhat incorrect as a “target” name because pseudogenes like RN7SL502P are nonfunctional and are not considered molecular targets in drug discovery or biomedical research.\n\nIf you require structured information for the functional 7SL RNA or the SRP complex, please clarify, as this entry refers to an inactive pseudogene.

Other names

RN7SL502P